Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

McMaster University

$100,000.00

Isoprostane-mediated regulation of airway and vascular smooth muscles

FY 2008-09

Summary
Arachidonic acid is a precursor for many molecules which regulate a wide variety of functions including blood pressure. Some of these are produced by specific enzymes (prostaglandins). However, in many diseases characterized by "oxidative stress" (pulmonary hypertension; acute lung injury; asthma), arachidonic acid and other membrane lipids are oxidized by free radicals to produce a different set of molecules known as isoprostanes: the latter are therefore currently recognized as useful ways to measure the disease states. However, they are not just markers: the isoprostanes themselves can exert powerful effects upon every cell type in the lung, including airway smooth muscle, pulmonary arteries/veins, bronchial artery, airway epithelium, cholinergic innervation and the pulmonary lymphatics (see Appendices 1-5 and Figures 4-10). To date, there have been only a few studies of the effects which isoprostanes exert on vascular tissues, and almost nothing is known about the receptors and signaling pathways through which they produce these changes. We intend to: Objective 1: determine exactly which isoprostane(s) are increased in acute lung injury and pulmonary hypertension (in humans and rat models); Objective 2: examine what functional changes they produce in the pulmonary artery (including effects on kinases/phosphatases, on ion channels and on Ca2+ handling); Objective 3: also probe their functional effects on the endothelium and pulmonary lymphatics; Objective 4: return to the animal models and assess whether blocking the effects of isoprostanes has any positive effects against those disease states.
Program
Operating Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
183811
Name
Janssen Luke J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Respiratory System
Projecttitle
Isoprostane-mediated regulation of airway and vascular smooth muscles
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Contraction; Isoprostanes; Patch-Clamp Electrophysiology; Prostanoids; Smooth Muscle
Abstract
Arachidonic acid is a precursor for many molecules which regulate a wide variety of functions including blood pressure. Some of these are produced by specific enzymes (prostaglandins). However, in many diseases characterized by "oxidative stress" (pulmonary hypertension; acute lung injury; asthma), arachidonic acid and other membrane lipids are oxidized by free radicals to produce a different set of molecules known as isoprostanes: the latter are therefore currently recognized as useful ways to measure the disease states. However, they are not just markers: the isoprostanes themselves can exert powerful effects upon every cell type in the lung, including airway smooth muscle, pulmonary arteries/veins, bronchial artery, airway epithelium, cholinergic innervation and the pulmonary lymphatics (see Appendices 1-5 and Figures 4-10). To date, there have been only a few studies of the effects which isoprostanes exert on vascular tissues, and almost nothing is known about the receptors and signaling pathways through which they produce these changes. We intend to: Objective 1: determine exactly which isoprostane(s) are increased in acute lung injury and pulmonary hypertension (in humans and rat models); Objective 2: examine what functional changes they produce in the pulmonary artery (including effects on kinases/phosphatases, on ion channels and on Ca2+ handling); Objective 3: also probe their functional effects on the endothelium and pulmonary lymphatics; Objective 4: return to the animal models and assess whether blocking the effects of isoprostanes has any positive effects against those disease states.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Janssen, Luke J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~